{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:06:06Z","timestamp":1793106366810,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13760-025-02764-5","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T21:21:17Z","timestamp":1742246477000},"page":"783-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating miR-223\/NLRP3 axis and IL-1\u03b2 level in functional disease progression of amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"125","author":[{"given":"Mitra Ansari","family":"Dezfouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Shalilahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Shamsaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Majdinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Khalil","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"2764_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fnins.2019.00532","volume":"13","author":"AM Ragagnin","year":"2019","unstructured":"Ragagnin AM et al (2019) Motor neuron susceptibility in ALS\/FTD. Front NeuroSci 13:532","journal-title":"Front NeuroSci"},{"key":"2764_CR2","doi-asserted-by":"crossref","unstructured":"Su W-M et al (2021) Predictors of survival in patients with amyotrophic lateral sclerosis: a large meta-analysis. EBioMedicine 74:103732","DOI":"10.1016\/j.ebiom.2021.103732"},{"key":"2764_CR3","doi-asserted-by":"publisher","first-page":"596006","DOI":"10.3389\/fneur.2021.596006","volume":"12","author":"M Keon","year":"2021","unstructured":"Keon M et al (2021) Destination amyotrophic lateral sclerosis. Front Neurol 12:596006","journal-title":"Front Neurol"},{"key":"2764_CR4","doi-asserted-by":"publisher","first-page":"105156","DOI":"10.1016\/j.nbd.2020.105156","volume":"147","author":"A Shatunov","year":"2021","unstructured":"Shatunov A, Al-Chalabi A (2021) The genetic architecture of ALS. Neurobiol Dis 147:105156","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2764_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41598-022-05067-4","volume":"12","author":"N Daneshafrooz","year":"2022","unstructured":"Daneshafrooz N et al (2022) Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Sci Rep 12(1):1373","journal-title":"Sci Rep"},{"issue":"1","key":"2764_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-022-00515-1","volume":"17","author":"KA Staats","year":"2022","unstructured":"Staats KA et al (2022) Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegeneration 17(1):11","journal-title":"Mol Neurodegeneration"},{"key":"2764_CR7","doi-asserted-by":"publisher","first-page":"552295","DOI":"10.3389\/fneur.2020.552295","volume":"11","author":"R Tortelli","year":"2020","unstructured":"Tortelli R et al (2020) Plasma inflammatory cytokines are elevated in ALS. Front Neurol 11:552295","journal-title":"Front Neurol"},{"key":"2764_CR8","doi-asserted-by":"publisher","first-page":"1190219","DOI":"10.3389\/fimmu.2023.1190219","volume":"14","author":"M-L Cl\u00e9net","year":"2023","unstructured":"Cl\u00e9net M-L et al (2023) Divergent functional outcomes of NLRP3 Blockade downstream of multi-inflammasome activation: therapeutic implications for ALS. Front Immunol 14:1190219","journal-title":"Front Immunol"},{"key":"2764_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","volume":"252","author":"FL Anderson","year":"2023","unstructured":"Anderson FL et al (2023) NLRP3 inflammasome in neurodegenerative disease. Translational Res 252:21\u201333","journal-title":"Translational Res"},{"issue":"2","key":"2764_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.23728","volume":"68","author":"V Deora","year":"2020","unstructured":"Deora V et al (2020) The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68(2):407\u2013421","journal-title":"Glia"},{"key":"2764_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2023.07.009","volume-title":"Inflammasome assembly in neurodegenerative diseases","author":"J Singh","year":"2023","unstructured":"Singh J, Habean ML, Panicker N (2023) Inflammasome assembly in neurodegenerative diseases. Trends in Neurosciences"},{"key":"2764_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","volume":"41","author":"A Gugliandolo","year":"2018","unstructured":"Gugliandolo A et al (2018) NLRP3 inflammasome activation in a Transgenic amyotrophic lateral sclerosis model. Inflammation 41:93\u2013103","journal-title":"Inflammation"},{"issue":"5","key":"2764_CR13","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/ijms22052523","volume":"22","author":"L Moreno-Garc\u00eda","year":"2021","unstructured":"Moreno-Garc\u00eda L et al (2021) Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker. Int J Mol Sci 22(5):2523","journal-title":"Int J Mol Sci"},{"key":"2764_CR14","doi-asserted-by":"crossref","unstructured":"Rashidi SK et al (2023) The role of MicroRNAs in neurobiology and pathophysiology of the hippocampus. Front Mol Neurosci 16:1226413","DOI":"10.3389\/fnmol.2023.1226413"},{"issue":"1","key":"2764_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of MicroRNAs in neurodegenerative diseases: a review. Cell Biol Toxicol 39(1):53\u201383","journal-title":"Cell Biol Toxicol"},{"key":"2764_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","volume":"516","author":"Y Wu","year":"2021","unstructured":"Wu Y et al (2021) Circulating MicroRNAs: biomarkers of disease. Clin Chim Acta 516:46\u201354","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2764_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10142-023-01268-w","volume":"23","author":"C Wu","year":"2023","unstructured":"Wu C et al (2023) NLRP3\/miR-223-3p axis attenuates neuroinflammation induced by chronic intermittent hypoxia. Funct Integr Genom 23(4):342","journal-title":"Funct Integr Genom"},{"issue":"4","key":"2764_CR18","doi-asserted-by":"publisher","first-page":"e3385","DOI":"10.1002\/jgm.3385","volume":"24","author":"J Ji","year":"2022","unstructured":"Ji J, Ye W, Sun G (2022) LncRNA OIP5-AS1 knockdown or miR\u2010223 overexpression can alleviate LPS\u2010induced ALI\/ARDS by interfering with miR-223\/NLRP3-mediated pyroptosis. J Gene Med 24(4):e3385","journal-title":"J Gene Med"},{"key":"2764_CR19","doi-asserted-by":"publisher","first-page":"113286","DOI":"10.1016\/j.ecoenv.2022.113286","volume":"232","author":"X Kong","year":"2022","unstructured":"Kong X et al (2022) GSDMD-miR-223-NLRP3 axis involved in B (a) P-induced inflammatory injury of alveolar epithelial cells. Ecotoxicol Environ Saf 232:113286","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"2764_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11280","volume":"23","author":"T Huang","year":"2022","unstructured":"Huang T et al (2022) miR\u2013223 ameliorates thalamus hemorrhage\u2013induced central poststroke pain via targeting NLRP3 in a mouse model. Experimental Therapeutic Med 23(5):1\u201314","journal-title":"Experimental Therapeutic Med"},{"issue":"3","key":"2764_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/path.5846","volume":"256","author":"P Banerjee","year":"2022","unstructured":"Banerjee P et al (2022) NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis. J Pathol 256(3):262\u2013268","journal-title":"J Pathol"},{"issue":"6","key":"2764_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/nan.12483","volume":"44","author":"S Lehmann","year":"2018","unstructured":"Lehmann S et al (2018) Expression profile of pattern recognition receptors in skeletal muscle of SOD1 (G93A) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients. Neuropathol Appl Neurobiol 44(6):606\u2013627","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"2764_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-022-02466-9","volume":"144","author":"E Van Schoor","year":"2022","unstructured":"Van Schoor E et al (2022) Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex. Acta Neuropathol 144(3):393\u2013411","journal-title":"Acta Neuropathol"},{"key":"2764_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","volume":"273","author":"W Zhao","year":"2015","unstructured":"Zhao W et al (2015) TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome. Exp Neurol 273:24\u201335","journal-title":"Exp Neurol"},{"key":"2764_CR25","doi-asserted-by":"crossref","unstructured":"Shu X et al (2023) Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome. Cell Rep 42(2):1\u201317","DOI":"10.1016\/j.celrep.2023.112133"},{"issue":"10","key":"2764_CR26","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3390\/antiox12101896","volume":"12","author":"R-H Fu","year":"2023","unstructured":"Fu R-H, Chen H-J, Hong S-Y (2023) Glycine-Alanine dipeptide repeat protein from C9-ALS interacts with sulfide Quinone oxidoreductase (SQOR) to induce the activity of the NLRP3 inflammasome in HMC3 microglia: Irisflorentin reverses this interaction. Antioxidants 12(10):1896","journal-title":"Antioxidants"},{"issue":"12","key":"2764_CR27","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann S et al (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63(12):2260\u20132273","journal-title":"Glia"},{"issue":"1","key":"2764_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bpa.12467","volume":"28","author":"B Debye","year":"2018","unstructured":"Debye B et al (2018) Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1 (G93A) ALS mice. Brain Pathol 28(1):14\u201327","journal-title":"Brain Pathol"},{"issue":"3","key":"2764_CR29","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1002\/mco2.249","volume":"4","author":"X Jin","year":"2023","unstructured":"Jin X et al (2023) Role of pyroptosis in the pathogenesis and treatment of diseases. MedComm 4(3):e249","journal-title":"MedComm"},{"issue":"5464","key":"2764_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1126\/science.288.5464.335","volume":"288","author":"M Li","year":"2000","unstructured":"Li M et al (2000) Functional role of caspase-1 and caspase-3 in an ALS Transgenic mouse model. Science 288(5464):335\u2013339","journal-title":"Science"},{"issue":"1","key":"2764_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12868-022-00733-9","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H et al (2022) Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model. BMC Neurosci 23(1):50","journal-title":"BMC Neurosci"},{"issue":"7","key":"2764_CR32","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.4103\/1673-5374.330591","volume":"17","author":"B Martinez","year":"2022","unstructured":"Martinez B, Peplow PV (2022) MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Neural Regeneration Res 17(7):1412\u20131422","journal-title":"Neural Regeneration Res"},{"key":"2764_CR33","doi-asserted-by":"crossref","unstructured":"Rashidi SK et al (2024) Melatonin attenuates methamphetamine neurotoxicity through Inhibition of NLRP3 and pyroptosis pathway. Physiol Pharmacol 28(4):430\u2013439","DOI":"10.61186\/phypha.28.4.430"},{"issue":"12","key":"2764_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/cells13120995","volume":"13","author":"H Cihankaya","year":"2024","unstructured":"Cihankaya H et al (2024) Elevated NLRP3 inflammasome activation is associated with motor neuron degeneration in ALS. Cells 13(12):995","journal-title":"Cells"},{"issue":"3\u20134","key":"2764_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/21678421.2021.1879865","volume":"22","author":"RP van Eijk","year":"2021","unstructured":"van Eijk RP et al (2021) An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degeneration 22(3\u20134):300\u2013307","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"key":"#cr-split#-2764_CR36.1","doi-asserted-by":"crossref","unstructured":"Sharma S et al (2024) Brain-Penetrant NF-\u03baB and NLRP3 Targeting Nanoligomers are Therapeutic in Amyotrophic Lateral Sclerosis (ALS) and Alzheimers Disease","DOI":"10.1101\/2024.03.07.583991"},{"key":"#cr-split#-2764_CR36.2","unstructured":"(AD) Human Organoid and Mouse Models. bioRxiv,: p. 2024.03. 07.583991"},{"issue":"3\u20134","key":"2764_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/21678421.2020.1813310","volume":"22","author":"M Wosiski-Kuhn","year":"2021","unstructured":"Wosiski-Kuhn M et al (2021) Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degeneration 22(3\u20134):248\u2013259","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"issue":"29","key":"2764_CR38","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.1002396107","volume":"107","author":"F Meissner","year":"2010","unstructured":"Meissner F, Molawi K, Zychlinsky A (2010) Mutant superoxide dismutase 1-induced IL-1\u03b2 accelerates ALS pathogenesis. Proc Natl Acad Sci 107(29):13046\u201313050","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2764_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/ijms21020387","volume":"21","author":"I Ozen","year":"2020","unstructured":"Ozen I et al (2020) Interleukin-1 beta neutralization attenuates traumatic brain injury-induced microglia activation and neuronal changes in the globus pallidus. Int J Mol Sci 21(2):387","journal-title":"Int J Mol Sci"},{"key":"2764_CR40","doi-asserted-by":"publisher","first-page":"707696","DOI":"10.3389\/fphar.2021.707696","volume":"12","author":"Q Yu","year":"2021","unstructured":"Yu Q et al (2021) Targeting NLRP3 inflammasome in translational treatment of nervous system diseases: an update. Front Pharmacol 12:707696","journal-title":"Front Pharmacol"},{"issue":"10","key":"2764_CR41","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1093\/brain\/awz245","volume":"142","author":"B Morquette","year":"2019","unstructured":"Morquette B et al (2019) MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis. Brain 142(10):2979\u20132995","journal-title":"Brain"},{"issue":"4","key":"2764_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cbf.3184","volume":"34","author":"LH Jia","year":"2016","unstructured":"Jia LH, Liu YN (2016) Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease. Cell Biochem Funct 34(4):233\u2013237","journal-title":"Cell Biochem Funct"},{"key":"2764_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fgene.2018.00310","volume":"9","author":"B De Felice","year":"2018","unstructured":"De Felice B et al (2018) Wide-ranging analysis of MicroRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front Genet 9:310","journal-title":"Front Genet"},{"issue":"1","key":"2764_CR44","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.1038\/s41598-019-45687-x","volume":"9","author":"R Mancuso","year":"2019","unstructured":"Mancuso R et al (2019) Circulatory miR-223-3p discriminates between Parkinson\u2019s and Alzheimer\u2019s patients. Sci Rep 9(1):9393","journal-title":"Sci Rep"},{"issue":"7","key":"2764_CR45","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.celrep.2018.01.058","volume":"22","author":"W Zhou","year":"2018","unstructured":"Zhou W et al (2018) MicroRNA-223 suppresses the canonical NF-\u03baB pathway in basal keratinocytes to dampen neutrophilic inflammation. Cell Rep 22(7):1810\u20131823","journal-title":"Cell Rep"},{"key":"2764_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-015-1772-1","volume":"16","author":"PI Fuller-Carter","year":"2015","unstructured":"Fuller-Carter PI et al (2015) Integrated analyses of zebrafish MiRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration. BMC Genomics 16:1\u201319","journal-title":"BMC Genomics"},{"issue":"9","key":"2764_CR47","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.59876","volume":"17","author":"P Jiao","year":"2021","unstructured":"Jiao P et al (2021) miR-223: an effective regulator of immune cell differentiation and inflammation. Int J Biol Sci 17(9):2308","journal-title":"Int J Biol Sci"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02764-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:03:51Z","timestamp":1748660631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02764-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02764-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has been approved by Ahvaz Jundishapur University of Medical Sciences with the approval code: IR.AJUMS.HGOLESTAN.REC.1402.155. The protocol number assign to the study was U-02301. All processes of the current research were according to the Declaration of Helsinki. All patients were informed about the nature of the research and signed a consent form before inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}